Phosphorylation of GSK-3β in AML may activate the Akt pathway and is associated with poorer overall survival; genomic loss of EZH2 may lead to epigenetic changes and overexpression of HOX genes. The gene discussed is AKT1; the disease is acute myeloid leukemia.